CERT / Certara Inc. (CERT) Q2 2023 Earnings Call Transcript

Certara, Inc. provides biosimulation software and services to the biotech and biopharma industry. The company is enjoying sales growth from its softwa more_horizontal

Certara Inc. CERT, -2.56% stock was down 14.6% in premarket trades on Thursday after the biotech software company missed Wall Street's adjusted earnin more_horizontal

Certara Inc. (NASDAQ:CERT ) Q2 2023 Results Conference Call August 9, 2023 5:00 PM ET Company Participants David Deuchler - IR William Feehery - CEO a more_horizontal

PRINCETON, N.J., June 02, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that Company manage more_horizontal

Certara, Inc. (NASDAQ:CERT ) Q1 2023 Results Conference Call May 8, 2023 5:00 PM ET Company Participants David Deuchler - IR William Feehery - CEO Joh more_horizontal

Certara, Inc. (CERT) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions. more_horizontal

Certara, Inc. (CERT) delivered earnings and revenue surprises of 14.29% and 4.34%, respectively, for the quarter ended December 2022. Do the numbers h more_horizontal

Unlike Schrodinger, Certara posted a profit in the last quarter. Business momentum is accelerating as backlog grows. more_horizontal